172 related articles for article (PubMed ID: 28066307)
1. Illness Representations of HIV Positive Patients Are Associated with Virologic Success.
Leone D; Borghi L; Lamiani G; Barlascini L; Bini T; d'Arminio Monforte A; Vegni E
Front Psychol; 2016; 7():1991. PubMed ID: 28066307
[No Abstract] [Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251.
Robbins GK; Cohn SE; Harrison LJ; Smeaton L; Moran L; Rusin D; Dehlinger M; Flynn T; Lammert S; Wu AW; Safren SA; Reynolds NR
HIV Clin Trials; 2016 Jul; 17(4):165-72. PubMed ID: 27347650
[TBL] [Abstract][Full Text] [Related]
4. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.
Pence BW; Miller WC; Gaynes BN; Eron JJ
J Acquir Immune Defic Syndr; 2007 Feb; 44(2):159-66. PubMed ID: 17146374
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.
Tuldrà A; Fumaz CR; Ferrer MJ; Bayés R; Arnó A; Balagué M; Bonjoch A; Jou A; Negredo E; Paredes R; Ruiz L; Romeu J; Sirera G; Tural C; Burger D; Clotet B
J Acquir Immune Defic Syndr; 2000 Nov; 25(3):221-8. PubMed ID: 11115952
[TBL] [Abstract][Full Text] [Related]
7. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors.
Maggiolo F; Ravasio L; Ripamonti D; Gregis G; Quinzan G; Arici C; Airoldi M; Suter F
Clin Infect Dis; 2005 Jan; 40(1):158-63. PubMed ID: 15614706
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with HIV virologic failure among patients on HAART for one year at three sentinel surveillance sites in China.
Wang X; Yang L; Li H; Zuo L; Liang S; Liu W; Dong Y; Yang S; Shang H; Li J; Kang L; Zhong P; Zheng W; Liao L; Xing H; Chen RY; Ruan Y; Shao Y
Curr HIV Res; 2011 Mar; 9(2):103-11. PubMed ID: 21361864
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors associated with virologic failure in HIV- infected patients receiving antiretroviral therapy at a public hospital in Peru].
Alave J; Paz J; González E; Campos M; Rodríguez M; Willig J; Echevarría J
Rev Chilena Infectol; 2013 Feb; 30(1):42-8. PubMed ID: 23450408
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.
Silveira MP; Maurer P; Guttier MC; Moreira LB
J Clin Pharm Ther; 2015 Apr; 40(2):192-5. PubMed ID: 25422132
[TBL] [Abstract][Full Text] [Related]
11. Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors.
Knobel H; Guelar A; Carmona A; Espona M; González A; López-Colomés JL; Saballs P; Gimeno JL; Díez A
AIDS Patient Care STDS; 2001 Apr; 15(4):193-9. PubMed ID: 11359661
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing illness representations and perceived adherence in haemophilic patients: a pilot study.
Lamiani G; Strada I; Mancuso ME; Coppola A; Vegni E; Moja EA;
Haemophilia; 2015 Sep; 21(5):598-604. PubMed ID: 25684356
[TBL] [Abstract][Full Text] [Related]
13. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania.
Ramadhani HO; Thielman NM; Landman KZ; Ndosi EM; Gao F; Kirchherr JL; Shah R; Shao HJ; Morpeth SC; McNeill JD; Shao JF; Bartlett JA; Crump JA
Clin Infect Dis; 2007 Dec; 45(11):1492-8. PubMed ID: 17990233
[TBL] [Abstract][Full Text] [Related]
14. How late is too late? Timeliness to scheduled visits as an antiretroviral therapy adherence measure in Nairobi, Kenya and Lusaka, Zambia.
Blacher RJ; Muiruri P; Njobvu L; Mutsotso W; Potter D; Ong'ech J; Mwai P; Degroot A; Zulu I; Bolu O; Stringer J; Kiarie J; Weidle PJ
AIDS Care; 2010 Nov; 22(11):1323-31. PubMed ID: 20711886
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of Youth Living With HIV to Optimize Adherence and Virologic Suppression: Testing the Design of Technology-Based Community Health Nursing to Improve Antiretroviral Therapy (ART) Clinical Trials.
Agwu AL; Yusuf HE; D'Angelo L; Rathore M; Marchesi J; Rowell J; Smith R; Toppins J; Trexler C; Carr R; Johnson B; Selden AK; Mahmoudi S; Black S; Guadamuz J; Huettner S; Trent M
JMIR Res Protoc; 2020 Dec; 9(12):e23480. PubMed ID: 33306036
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes.
Chung MH; Richardson BA; Tapia K; Benki-Nugent S; Kiarie JN; Simoni JM; Overbaugh J; Attwa M; John-Stewart GC
PLoS Med; 2011 Mar; 8(3):e1000422. PubMed ID: 21390262
[TBL] [Abstract][Full Text] [Related]
17. Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients.
Maggiolo F; Airoldi M; Kleinloog HD; Callegaro A; Ravasio V; Arici C; Bombana E; Suter F
HIV Clin Trials; 2007; 8(5):282-92. PubMed ID: 17956829
[TBL] [Abstract][Full Text] [Related]
18. Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.
Hart JE; Jeon CY; Ivers LC; Behforouz HL; Caldas A; Drobac PC; Shin SS
J Acquir Immune Defic Syndr; 2010 Jun; 54(2):167-79. PubMed ID: 20375848
[TBL] [Abstract][Full Text] [Related]
19. Virologic success in an urban HIV clinic: outcome at 12 months in patients who were HAART naïve.
Blanchard E; Klibanov OM; Axelrod P; Palermo B; Samuel R
HIV Clin Trials; 2008; 9(3):186-91. PubMed ID: 18547905
[TBL] [Abstract][Full Text] [Related]
20. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
